Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The gross margin is N/A as of Tuesday, October 6, 2026.
GROSS MARGIN
N/A
Market Cap
$135.46M
Gross Margin
57.63%
TTM Avg
59.89%
3Y Avg
61.87%
5Y Avg
62.78%
Market Cap
$133.80M
Gross Margin
82.77%
TTM Avg
89.91%
3Y Avg
44.96%
5Y Avg
29.97%
Market Cap
$133.34M
Gross Margin
3.67%
TTM Avg
16.70%
3Y Avg
18.97%
5Y Avg
8.54%
Market Cap
$133.19M
Gross Margin
33.47%
TTM Avg
39.70%
3Y Avg
43.04%
5Y Avg
44.80%
Market Cap
$136.36M
Gross Margin
97.90%
TTM Avg
100.00%
3Y Avg
100.00%
5Y Avg
100.00%
Market Cap
$136.66M
Gross Margin
61.99%
TTM Avg
62.83%
3Y Avg
59.84%
5Y Avg
59.96%
Market Cap
$139.73M
Gross Margin
62.53%
TTM Avg
65.36%
3Y Avg
65.75%
5Y Avg
64.06%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Freenome, Inc. (FRNM) | $134.75M | N/A | N/A | N/A | N/A |
| LifeMD, Inc. (LFMD)vs › | $134.21M | 85.91% | 84.21% | 85.09% | 82.87% |
| AirSculpt Technologies, Inc. (AIRS)vs › | $135.46M | 57.63% | 59.89% | 61.87% | 62.78% |
| Pyxis Oncology, Inc. (PYXS)vs › | $133.80M | 82.77% | 89.91% | 44.96% | 29.97% |
| Organigram Global Inc. (OGI)vs › | $133.34M | 3.67% | 16.70% | 18.97% | 8.54% |
| Health Catalyst, Inc. (HCAT)vs › | $133.19M | 33.47% | 39.70% | 43.04% | 44.80% |
| Atrium Therapeutics, Inc. (RNA)vs › | $136.36M | 97.90% | 100.00% | 100.00% | 100.00% |
| KORU Medical Systems, Inc. (KRMD)vs › | $136.66M | 61.99% | 62.83% | 59.84% | 59.96% |
| Fortress Biotech, Inc. (FBIOP)vs › | $139.73M | 62.53% | 65.36% | 65.75% | 64.06% |
| Alpha Cognition Inc (ACOG)vs › | $139.63M | 81.26% | 40.63% | 20.32% | 13.54% |
Gross Margin
N/A
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
